In Re: Akorn, Inc. Data Integrity Securities Litigation

  1. March 13, 2020

    Akorn Lands Final OK For $30M Deal Over Failed Merger

    An Illinois federal judge granted final approval on Friday to a settlement that would provide Akorn Inc.'s investors with $30 million in cash and resolve claims that the drugmaker's misconduct sunk a multibillion-dollar merger.

  2. August 26, 2019

    Akorn's $30M Investor Deal Over Failed Merger Gets 1st OK

    An Illinois federal judge granted preliminary approval on Monday to a settlement that would provide Akorn Inc.'s investors $30 million in cash and resolve claims that the drugmaker's misconduct sunk a multibillion-dollar merger.

  3. August 12, 2019

    Akorn Seeks OK On $30M Deal Over Failed Merger

    Pharmaceutical manufacturer Akorn Inc. and its investors settled a suit that would provide $30 million in cash and distribute more than 8 million shares of Akorn stock to class members, according to a motion for preliminary approval filed Friday in Illinois federal court.

  4. July 08, 2019

    Akorn Investors Seek Cert. In Suit Over Failed Merger

    Akorn Inc. investors have asked an Illinois federal judge for class certification in their securities fraud suit claiming the generic-drug maker and its executives falsified regulatory submissions that sunk a multibillion-dollar merger and tanked Akorn's share price.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!